[PDF][PDF] Neuroendocrine prostate cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and …
HT Wang, YH Yao, BG Li, Y Tang… - Journal of Clinical …, 2014 - scholar.archive.org
HT Wang, YH Yao, BG Li, Y Tang, JW Chang, J Zhang
Journal of Clinical Oncology, 2014•scholar.archive.orgPurpose An often under-recognized late manifestation of prostate adenocarcinoma (PCa) is
the development of treatment-related neuroendocrine prostate cancer (NEPC). The aim of
this study is to identify the risk factors related to survival after NEPC diagnosis (NEPCS) and
time from initial diagnosis of PCa to development of NEPC (TTNEPC).
the development of treatment-related neuroendocrine prostate cancer (NEPC). The aim of
this study is to identify the risk factors related to survival after NEPC diagnosis (NEPCS) and
time from initial diagnosis of PCa to development of NEPC (TTNEPC).
Purpose
An often under-recognized late manifestation of prostate adenocarcinoma (PCa) is the development of treatment-related neuroendocrine prostate cancer (NEPC). The aim of this study is to identify the risk factors related to survival after NEPC diagnosis (NEPCS) and time from initial diagnosis of PCa to development of NEPC (TTNEPC).
scholar.archive.org